Iaso Therapeutics develops vaccines to improve human health and cure diseases.
Iaso Therapeutics has raised $125K in total funding. The most recent round was Grant. The last funding was announced in January 2023.
Iaso Therapeutics's investors include National Science Foundation, Michigan Rise, Red Cedar Ventures, National Institute of Allergy and Infectious Diseases, Michigan Emerging Technology Fund.
Iaso Therapeutics is headquartered in East Lansing, United States.
Iaso Therapeutics develops vaccines to improve human health and cure diseases.
Iaso Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Iaso Therapeutics — Funding & Investors." VCBacked, January 25, 2023, https://www.vcbacked.co/company/iaso-therapeutics. Accessed August 14, 2026.
VCBacked. (2023). Iaso Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/iaso-therapeutics
{{cite web |title=Iaso Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/iaso-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated